Dayson Moreira

1.4k citations

33 papers · 1.1k indexed · h-index 18

Co-authors: Marcin Kortylewski José Ernesto Belizário Stephen J. Forman Sumanta K. Pal Haejung Won Dewan Md Sakib Hossain Qifang Zhang Piotr Swiderski
Topics: Cytokine Signaling Pathways and Interactions (10 papers)Immune cells in cancer (8 papers)Immune Response and Inflammation (7 papers)
Cited by: Immunology Oncology Cancer Research
Journals: Journal of Clinical Investigation Journal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations: United States Brazil Poland

In The Last Decade

Dayson Moreira

33 papers receiving 1.1k citations

Peers

Countries citing papers authored by Dayson Moreira

Since Specialization

Citations

This map shows the geographic impact of Dayson Moreira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dayson Moreira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dayson Moreira more than expected).

Fields of papers citing papers by Dayson Moreira

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dayson Moreira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dayson Moreira. The network helps show where Dayson Moreira may publish in the future.

Co-authorship network of co-authors of Dayson Moreira

This figure shows the co-authorship network connecting the top 25 collaborators of Dayson Moreira. A scholar is included among the top collaborators of Dayson Moreira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dayson Moreira. Dayson Moreira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy 2024 ·Frontiers in Immunology ·Marice Alcantara,(unknown),Dongfang Wang,(unknown),Elaine Kang,Nazlı Dizman,Alex Chehrazi‐Raffle,Luís Meza,Zeynep Büşra Zengin,Jérémy Hall,Joann Hsu,Colt A. Egelston,Dayson Moreira,Alan Horsager,Sumanta K. Pal,Marcin Kortylewski	10
2	Large, Anionic Liposomes Enable Targeted Intraperitoneal Delivery of a TLR 7/8 Agonist To Repolarize Ovarian Tumors’ Microenvironment 2021 ·Bioconjugate Chemistry ·Elaine Kang,(unknown),(unknown),(unknown),Tom Haber,(unknown),Dayson Moreira,(unknown),(unknown),Yijia Zhang,Mohamed Hammad,Marcin Kortylewski,Karen S. Aboody,Jacob M. Berlin	25
3	Myeloid cell–targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell–mediated immunity 2020 ·Journal of Clinical Investigation ·Dayson Moreira,Sagus Sampath,Haejung Won,(unknown),Yu‐Lin Su,Marice Alcantara,Chongkai Wang,Peter P. Lee,Ellie Maghami,Erminia Massarelli,Marcin Kortylewski	71
4	Automated in Vivo Assessment of Vascular Response to Radiation Using a Hybrid Theranostic X-Ray Irradiator/Fluorescence Molecular Imaging System 2020 ·IEEE Access ·Farouk Nouizi,(unknown),(unknown),(unknown),Dayson Moreira,Marcin Kortylewski,Jerry Froelich,Min‐Ying Su,Gültekin Gülşen,Susanta Hui	2
5	Targeted In Vivo Delivery of NF-κB Decoy Inhibitor Augments Sensitivity of B Cell Lymphoma to Therapy 2020 ·Molecular Therapy ·Zhuoran Zhang,Xingli Zhao,Dongfang Wang,Dayson Moreira,Yu‐Lin Su,Marice Alcantara,Piotr Swiderski,Jeffrey Y.C. Wong,Susanta Hui,Stephen J. Forman,Larry W. Kwak,Marcin Kortylewski	8
6	Myeloid cell–targeted miR-146a mimic inhibits NF-κB–driven inflammation and leukemia progression in vivo 2019 ·Blood ·Yu‐Lin Su,Xiuli Wang,Mati Mann,Tomasz Adamus,Dongfang Wang,Dayson Moreira,Zhuoran Zhang,Ching Ouyang,Xin He,Bin Zhang,Piotr Swiderski,Stephen J. Forman,David Baltimore,Ling Li,Guido Marcucci,Mark Boldin,Marcin Kortylewski	97
7	STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers 2018 ·Clinical Cancer Research ·Dayson Moreira,Tomasz Adamus,Xingli Zhao,(unknown),Zhuoran Zhang,(unknown),Piotr Swiderski,Xin Lü,Ronald A. DePinho,Sumanta K. Pal,Marcin Kortylewski	64
8	Inhibition of Survival Signaling in B-Cell Lymphoma Using TLR9-Targeted Delivery of NF-Kb Decoy Oligodeoxynucleotides in Vitro and in Vivo 2018 ·Experimental Hematology ·Zhuoran Zhang,Dayson Moreira,Yu‐Lin Su,Piotr Swiderski,Defu Zeng,Marcin Kortylewski	1
9	B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors 2018 ·Molecular Therapy ·Xingli Zhao,Zhuoran Zhang,Dayson Moreira,Yu‐Lin Su,Haejung Won,Tomasz Adamus,Zhenyuan Dong,Yong Liang,Hongwei Yin,Piotr Swiderski,Raju Pillai,Larry W. Kwak,Stephen J. Forman,Marcin Kortylewski	26
10	Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities 2017 ·Cancer Immunology Immunotherapy ·Marcin Kortylewski,Dayson Moreira	45
11	Using Pharmacogenomic Databases for Discovering Patient-Target Genes and Small Molecule Candidates to Cancer Therapy 2016 ·Frontiers in Pharmacology ·José Ernesto Belizário,(unknown),(unknown),(unknown),Dayson Moreira	22
12	TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients 2015 ·Clinical Cancer Research ·Dewan Md Sakib Hossain,Sumanta K. Pal,Dayson Moreira,Priyanka Duttagupta,Qifang Zhang,Haejung Won,Jeremy Jones,Massimo D’Apuzzo,Stephen J. Forman,Marcin Kortylewski	156
13	TLR9-Targeted SiRNA Delivery In Vivo 2015 ·Methods in molecular biology ·Dewan Md Sakib Hossain,Dayson Moreira,Qifang Zhang,Sergey Nechaev,Piotr Swiderski,Marcin Kortylewski	6
14	Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling 2015 ·BMC Cancer ·(unknown),Dayson Moreira,Daniel R. Carrasco,Jun Yao,Dale Porter,Ricardo Olímpio de Moura,Anamaria A. Camargo,Cibely Cristine Fontes de Oliveira,Miguel Garay-Malpartida,Silvia Carambula,Edouard Vannier,Bryan E. Strauss,Alda Wakamatsu,Venâncio Avancini Ferreira Alves,Ângela Flávia Logullo,Fernando Augusto Soares,Kornélia Polyák,José Ernesto Belizário	21
15	Cell Death-Associated Molecular-Pattern Molecules: Inflammatory Signaling and Control 2014 ·Mediators of Inflammation ·(unknown),(unknown),Dayson Moreira,José Ernesto Belizário	106
16	Intracellular processing of immunostimulatory CpG–siRNA: Toll-like receptor 9 facilitates siRNA dicing and endosomal escape 2013 ·Journal of Controlled Release ·Sergey Nechaev,Chan Gao,Dayson Moreira,Piotr Swiderski,(unknown),Claudia Kowolik,Jiehua Zhou,Brian Armstrong,Andrew Raubitschek,John J. Rossi,Marcin Kortylewski	42
17	Bortezomib (PS-341) Treatment Decreases Inflammation and Partially Rescues the Expression of the Dystrophin-Glycoprotein Complex in GRMD Dogs 2013 ·PLoS ONE ·(unknown),Gloria Bonuccelli,(unknown),Thaís Peixoto Gaiad,Dayson Moreira,David Feder,José Ernesto Belizário,María Angélica Miglino,Michael P. Lisanti,Carlos Eduardo Ambrósio	33
18	Identification of a metallopeptidase with TOP-like activity inParacoccidioides brasiliensis, with increased expression in a virulent strain 2012 ·Medical Mycology ·(unknown),Thaysa Paschoalin,(unknown),Dayson Moreira,José Ernesto Belizário,Vitor Oliveira,Adriana K. Carmona,María A. Juliano,Luiz R. Travassos,Elaine G. Rodrigues	4
19	Role of SOCS-1 Gene on Melanoma Cell Growth and Tumor Development 2011 ·Translational Oncology ·(unknown),Alisson L. Matsuo,Felipe V. Pereira,Mariana H. Massaoka,Carlos R. Figueiredo,Dayson Moreira,José Ernesto Belizário,Luiz R. Travassos	21
20	Genes up- and down-regulated by dermcidin in breast cancer: a microarray analysis 2008 ·Genetics and Molecular Research ·Dayson Moreira,Bryan E. Strauss,Edouard Vannier,José Ernesto Belizário	8

About Dayson Moreira

Dayson Moreira is a scholar working on Immunology, Oncology and Cancer Research, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (10 papers), Immune cells in cancer (8 papers) and Immune Response and Inflammation (7 papers). The work is most often cited by research in Immunology (494 citations), Oncology (469 citations) and Cancer Research (200 citations). Dayson Moreira has collaborated with scholars based in United States, Brazil and Poland. Frequent co-authors include Marcin Kortylewski, José Ernesto Belizário, Stephen J. Forman, Sumanta K. Pal, Haejung Won, Dewan Md Sakib Hossain, Qifang Zhang, Piotr Swiderski, Priyanka Duttagupta and Massimo D’Apuzzo. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact